Flowserve Is Headed for New Highs

Shares of Flowserve (FLS) are ripping on Thursday. The diversified machinery company is one of the top five performers in the S&P 500, with the help of a nearly 7% surge.

This powerful move has driven the stock past layers of resistance and has set the stage for more gains. In the near term, patient Flowserve investors should consider the stock a buy on weakness.

Back in early October, Flowserve was in full breakdown mode. By the middle of the month, the stock was slicing through key support near its 200-day moving average. This steep selloff accelerated dramatically on the morning of Oct. 28 as investors aggressively sold shares in reaction to Flowserve's  third-quarter earnings report. The stock opened that session with a huge downside gap as it stretched the drop from the October peak to 20%.

The steep drop immediately after earnings marked a major spike low. Flowserve has been steadily rebounding since then. As a new rally leg takes shape, the stock is leaving behind layers of support.

In the near term, Flowserve bulls should keep a close eye on the $49.60 to $48.80 area. This zone marks the upper band of a new support area. The stock's April, July, August and October highs are in this area. A dip back down to this area would offer a very low-risk entry opportunity.

On the upside, Flowserve is set up well for a retest of the 2016 highs set back in June at $52.50.

Click here to see the below chart in a new window.

This article is commentary by an independent contributor. At the time of publication, the author held no position in the stocks mentioned.

More from Stocks

Dow Tumbles, Stocks Slide on Renewed Trade War Concerns

Dow Tumbles, Stocks Slide on Renewed Trade War Concerns

Here's Why Snap Shares Are Climbing Monday

Here's Why Snap Shares Are Climbing Monday

Dropbox Soars in Third-Straight Record-Setting Session

Dropbox Soars in Third-Straight Record-Setting Session

Tesla's Elon Musk Just Told Short-Sellers They're Toast

Tesla's Elon Musk Just Told Short-Sellers They're Toast

Jim Cramer: Centene Is in All the Big Medicare Markets

Jim Cramer: Centene Is in All the Big Medicare Markets